Loading clinical trials...
Loading clinical trials...
Single Country Study Assessing Cognition in Relapsing Remitting Multiple Sclerosis Patients Treated With BG00012
Conditions
Interventions
dimethyl fumarate
Locations
18
Italy
Research site
Bari, Italy
Research site
Cagliari, Italy
Research site
Catania, Italy
Research site
Cefalù, Italy
Research site
Chieti, Italy
Research site
Ferrara, Italy
Start Date
April 30, 2014
Primary Completion Date
December 21, 2016
Completion Date
December 21, 2016
Last Updated
April 27, 2017
NCT05359653
NCT06390930
NCT03401879
NCT06389968
NCT05834855
NCT06413602
Lead Sponsor
Biogen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions